Allen Institute Leads Global Effort to Create 'Rosetta Stone' for Brain Cells, Advancing Neurological Disease Research
The Seattle-based Allen Institute has played a pivotal role in a global consortium of 56 institutions across nine countries to develop a 'biological Rosetta Stone' for brain cells. This initiative, part of the BRAIN Initiative Cell Atlas Network (BICAN), aims to create a shared system for naming and describing cells in the basal ganglia across different species. The basal ganglia, a critical brain region, controls movement, emotions, motivation, and habits, and is implicated in disorders like schizophrenia, bipolar disorder, and Parkinson's disease. The research, published in a special issue of the journal Cell, involved analyzing 25.5 million brain cells, including 21 million human cells. Researchers utilized various techniques such as RNA sequencing, epigenomic studies, and electrical activity measurements to gather insights. Michael Hawrylycz, a principal investigator at the Allen Institute, highlighted the necessity of this groundwork for significant progress in understanding this complex brain region....
